Enforcement discretion for manufacturing to increase infant formula supplies in the US has been extended to early January as the Food and Drug Administration provides guidance for firms currently using temporary clearances to market their products to work toward becoming fully compliant.
“The guidance balances the need to ensure that infant formula products meet regulatory requirements with the need for a more...